193 related articles for article (PubMed ID: 24141567)
1. Cysteinyl leukotriene receptor 1 mediates LTD4-induced activation of mouse microglial cells in vitro.
Yu SY; Zhang XY; Wang XR; Xu DM; Chen L; Zhang LH; Fang SH; Lu YB; Zhang WP; Wei EQ
Acta Pharmacol Sin; 2014 Jan; 35(1):33-40. PubMed ID: 24141567
[TBL] [Abstract][Full Text] [Related]
2. [Effects of cysteinyl leukotriene receptors on phagocytosis of mouse microglial cells].
Wang X; Lu Y; Zhang W; Wei E; Fang S
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2018 Jan; 47(1):10-18. PubMed ID: 30146806
[TBL] [Abstract][Full Text] [Related]
3. [Leukotriene D4 activates BV2 microglia in vitro].
Zhang Z; Luo J; Huang J; Liu Z; Fang S; Zhang WP; Wei E; Lu Y
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2013 May; 42(3):253-60. PubMed ID: 23801612
[TBL] [Abstract][Full Text] [Related]
4. HAMI 3379, a CysLT2 receptor antagonist, attenuates ischemia-like neuronal injury by inhibiting microglial activation.
Zhang XY; Wang XR; Xu DM; Yu SY; Shi QJ; Zhang LH; Chen L; Fang SH; Lu YB; Zhang WP; Wei EQ
J Pharmacol Exp Ther; 2013 Aug; 346(2):328-41. PubMed ID: 23750020
[TBL] [Abstract][Full Text] [Related]
5. Agonist- and T(H)2 cytokine-induced up-regulation of cysteinyl leukotriene receptor messenger RNA in human monocytes.
Shirasaki H; Seki N; Fujita M; Kikuchi M; Kanaizumi E; Watanabe K; Himi T
Ann Allergy Asthma Immunol; 2007 Oct; 99(4):340-7. PubMed ID: 17941281
[TBL] [Abstract][Full Text] [Related]
6. Cysteinyl leukotriene receptor (CysLT) antagonists decrease pentylenetetrazol-induced seizures and blood-brain barrier dysfunction.
Lenz QF; Arroyo DS; Temp FR; Poersch AB; Masson CJ; Jesse AC; Marafiga JR; Reschke CR; Iribarren P; Mello CF
Neuroscience; 2014 Sep; 277():859-71. PubMed ID: 25090924
[TBL] [Abstract][Full Text] [Related]
7. Leukotriene D4 induces cellular senescence in osteoblasts.
Wei J; Chen S; Guo W; Feng B; Yang S; Huang C; Chu J
Int Immunopharmacol; 2018 May; 58():154-159. PubMed ID: 29587204
[TBL] [Abstract][Full Text] [Related]
8. Neutralization of leukotriene C4 and D4 activity by monoclonal and single-chain antibodies.
Kawakami Y; Hirano S; Kinoshita M; Otsuki A; Suzuki-Yamamoto T; Suzuki M; Kimoto M; Sasabe S; Fukushima M; Kishimoto K; Izumi T; Oga T; Narumiya S; Sugahara M; Miyano M; Yamamoto S; Takahashi Y
Biochim Biophys Acta; 2014 Jun; 1840(6):1625-33. PubMed ID: 24361619
[TBL] [Abstract][Full Text] [Related]
9. Allergen challenge-induced changes in bone-marrow responses to leukotriene D
Masid-de-Brito D; Vieira BM; de Souza CC; Silva F; Gaspar-Elsas MIC; Xavier-Elsas P
Immunopharmacol Immunotoxicol; 2020 Jun; 42(3):199-210. PubMed ID: 32122206
[No Abstract] [Full Text] [Related]
10. HAMI 3379, a CysLT2R antagonist, dose- and time-dependently attenuates brain injury and inhibits microglial inflammation after focal cerebral ischemia in rats.
Shi QJ; Wang H; Liu ZX; Fang SH; Song XM; Lu YB; Zhang WP; Sa XY; Ying HZ; Wei EQ
Neuroscience; 2015 Apr; 291():53-69. PubMed ID: 25681271
[TBL] [Abstract][Full Text] [Related]
11. Leukotriene D
Liu T; Barrett NA; Nagai J; Lai J; Feng C; Boyce JA
J Allergy Clin Immunol; 2021 Jul; 148(1):195-208.e5. PubMed ID: 33285161
[TBL] [Abstract][Full Text] [Related]
12. Regulation of rotenone-induced microglial activation by 5-lipoxygenase and cysteinyl leukotriene receptor 1.
Zhang XY; Chen L; Yang Y; Xu DM; Zhang SR; Li CT; Zheng W; Yu SY; Wei EQ; Zhang LH
Brain Res; 2014 Jul; 1572():59-71. PubMed ID: 24858057
[TBL] [Abstract][Full Text] [Related]
13. CysLT2 receptor mediates lipopolysaccharide-induced microglial inflammation and consequent neurotoxicity in vitro.
Chen L; Yang Y; Li CT; Zhang SR; Zheng W; Wei EQ; Zhang LH
Brain Res; 2015 Oct; 1624():433-445. PubMed ID: 26282348
[TBL] [Abstract][Full Text] [Related]
14. Cutting edge: Leukotriene C4 activates mouse platelets in plasma exclusively through the type 2 cysteinyl leukotriene receptor.
Cummings HE; Liu T; Feng C; Laidlaw TM; Conley PB; Kanaoka Y; Boyce JA
J Immunol; 2013 Dec; 191(12):5807-10. PubMed ID: 24244016
[TBL] [Abstract][Full Text] [Related]
15. Leukotriene D4 and prostaglandin E2 signals synergize and potentiate vascular inflammation in a mast cell-dependent manner through cysteinyl leukotriene receptor 1 and E-prostanoid receptor 3.
Kondeti V; Al-Azzam N; Duah E; Thodeti CK; Boyce JA; Paruchuri S
J Allergy Clin Immunol; 2016 Jan; 137(1):289-298. PubMed ID: 26255103
[TBL] [Abstract][Full Text] [Related]
16. Lung type 2 innate lymphoid cells express cysteinyl leukotriene receptor 1, which regulates TH2 cytokine production.
Doherty TA; Khorram N; Lund S; Mehta AK; Croft M; Broide DH
J Allergy Clin Immunol; 2013 Jul; 132(1):205-13. PubMed ID: 23688412
[TBL] [Abstract][Full Text] [Related]
17. Regulation of cysteinyl leukotriene type 1 receptor internalization and signaling.
Naik S; Billington CK; Pascual RM; Deshpande DA; Stefano FP; Kohout TA; Eckman DM; Benovic JL; Penn RB
J Biol Chem; 2005 Mar; 280(10):8722-32. PubMed ID: 15590629
[TBL] [Abstract][Full Text] [Related]
18. Leukotriene D4 accelerates antigen-mediated mast cell responses via the cysteinyl leukotriene 1 receptor.
Fujisawa S; Nagata Y; Suzuki R
Cell Immunol; 2022 Dec; 382():104632. PubMed ID: 36274438
[TBL] [Abstract][Full Text] [Related]
19. Leukotriene D4 stimulates collagen production from myofibroblasts transformed by TGF-beta.
Asakura T; Ishii Y; Chibana K; Fukuda T
J Allergy Clin Immunol; 2004 Aug; 114(2):310-5. PubMed ID: 15316508
[TBL] [Abstract][Full Text] [Related]
20. [Rotenone-induced changes of cysteinyl leukotriene receptor 1 expression in BV2 microglial cells].
Luo JY; Zhang Z; Yu SY; Zhao B; Zhao CZ; Wang XX; Fang SH; Zhang WP; Zhang LH; Wei EQ; Lu YB
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2011 Mar; 40(2):131-8. PubMed ID: 21488207
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
